These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 7522616)
1. Combination chemotherapy with COP-BLAM III for intermediate and high-grade non-Hodgkin's lymphoma. Niitsu N; Umeda M Int J Hematol; 1994 Jul; 60(1):71-8. PubMed ID: 7522616 [TBL] [Abstract][Full Text] [Related]
2. [The effects of COP-BLAM regimen with G-CSF for intermediate and high grade non-Hodgkin's lymphoma]. Niitsu N; Umeda M Rinsho Ketsueki; 1995 Feb; 36(2):84-90. PubMed ID: 7536279 [TBL] [Abstract][Full Text] [Related]
3. [The COP-BLAM III therapy of non-Hodgkin's lymphoma]. Arai N; Hara A; Umeda M; Shirai T Rinsho Ketsueki; 1991 Nov; 32(11):1447-52. PubMed ID: 1721937 [TBL] [Abstract][Full Text] [Related]
4. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma]. Niitsu N; Hara A; Umeda M; Shirai T Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661 [TBL] [Abstract][Full Text] [Related]
5. The COP-BLAM programs: evolving chemotherapy concepts in large cell lymphoma. Coleman M; Armitage JO; Gaynor M; McDermott D; Weisenburger DD; Adler K; Beshevkin M; Silver RT; Reisman AM; Pasmantier MW Semin Hematol; 1988 Apr; 25(2 Suppl 2):23-33. PubMed ID: 2456620 [TBL] [Abstract][Full Text] [Related]
6. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
7. COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma. Niitsu N; Umeda M Eur J Haematol; 1995 Aug; 55(2):88-92. PubMed ID: 7543059 [TBL] [Abstract][Full Text] [Related]
8. Pilot study of modified version of CHOP plus radiotherapy for early-stage aggressive non-Hodgkin's lymphoma of the head and neck. Nishioka T; Tsuchiya K; Nishioka S; Kitahara T; Ohmori K; Homma A; Aoyma H; Shindoh M; Shirato H Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):847-52. PubMed ID: 15465202 [TBL] [Abstract][Full Text] [Related]
9. [COP-BLAM III regimen for elderly non-Hodgkin's lymphoma]. Niitsu N; Umeda M; Shirai T Nihon Ronen Igakkai Zasshi; 1993 Sep; 30(9):753-8. PubMed ID: 7693992 [TBL] [Abstract][Full Text] [Related]
10. Biweekly COP-BLAM (cyclophosphamide, vincristine, prednisone, bleomycin, doxorubicin and procarbazine) regimen combined with granulocyte colony stimulating factor (G-CSF) for intermediate-grade non-Hodgkin's lymphoma. Niitsu N; Umeda M Eur J Haematol; 1996 Mar; 56(3):163-7. PubMed ID: 8598236 [TBL] [Abstract][Full Text] [Related]
11. Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas. Gerhartz HH; Engelhard M; Brittinger G; Schlimok G; Thiel E; Huber C; Emmerich B; Schadek C; Brandmaier R; Stern AC Semin Oncol; 1994 Dec; 21(6 Suppl 16):25-8. PubMed ID: 7528447 [No Abstract] [Full Text] [Related]
12. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL). Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of aggressive non-Hodgkin's lymphoma with the ProMACE- CytaBOM protocol]. Mihaljević B; Jancić-Nedeljkov R; Sretenović M; Milivojević G; Janković S; Petrović M Srp Arh Celok Lek; 1998; 126(9-10):345-8. PubMed ID: 9863405 [TBL] [Abstract][Full Text] [Related]
14. [Prognostic factors of follicular lymphoma treated with combination chemotherapy]. Niitsu N; Umeda M Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325 [TBL] [Abstract][Full Text] [Related]
15. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group. Smith GM; Child JA; Cullen MH; Bailey NP; Woodruffe CM; Fletcher J; Earl H; Barnard D Hematol Oncol; 1996 Dec; 14(4):193-201. PubMed ID: 9267465 [TBL] [Abstract][Full Text] [Related]
16. Stage I and II non-Hodgkin's lymphoma: results of combined of THP-COP chemotherapy and radiotherapy. Ohga S; Nakamura K; Shioyama Y; Sasaki T; Urashima Y; Terashima H; Honda H Radiat Med; 2005 May; 23(3):156-61. PubMed ID: 15940061 [TBL] [Abstract][Full Text] [Related]
17. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma]. Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071 [TBL] [Abstract][Full Text] [Related]
18. CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. Doorduijn JK; van der Holt B; van Imhoff GW; van der Hem KG; Kramer MH; van Oers MH; Ossenkoppele GJ; Schaafsma MR; Verdonck LF; Verhoef GE; Steijaert MM; Buijt I; Uyl-de Groot CA; van Agthoven M; Mulder AH; Sonneveld P J Clin Oncol; 2003 Aug; 21(16):3041-50. PubMed ID: 12915593 [TBL] [Abstract][Full Text] [Related]
19. [Comparison of CHOP and COP-BLAM chemotherapy in highly malignant non-Hodgkin's lymphoma]. Gerhartz HH; Thiel E; Hiller E; Nerl C; Wilmanns W; Huhn D Dtsch Med Wochenschr; 1986 Oct; 111(40):1511-5. PubMed ID: 2428572 [TBL] [Abstract][Full Text] [Related]
20. [A comparative study of CHOP therapy and COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients]. Arai N; Hara A; Kaneko H; Umeda M; Shirai T Nihon Ronen Igakkai Zasshi; 1991 Sep; 28(5):672-7. PubMed ID: 1721658 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]